Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer. Among patients with platinum-sensitive peritoneal ...

A retrospective study compared progression-free and overall survival of hyperthermic intraperitoneal chemotherapy with conventional intraperitoneal chemotherapy in patients with ovarian cancer.

Adding hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C to surgery for locally advanced colorectal cancer (CRC) significantly reduced the risk of locoregional recurrence, the ...

PHILADELPHIA (WPVI) -- A very specialized procedure is targeting some rare cancers. It's called HIPEC and it's a very specific type of chemotherapy done in tandem with surgery. In early 2019, ...

WEST PHILADELPHIA (WPVI) -- Chemotherapy is a lifesaver in cancer treatment. But an IV isn't always the best way to deliver it. A different technique is helping make a difference for some abdominal ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...

Tracy Gosson was shocked when she learned in 2019 that she had stage 4 ovarian cancer. With the cancer growing “at a lightning pace,” she underwent her first round of chemotherapy within three weeks ...

Doctors have used HIPEC, or heated chemotherapy, for years to treat certain abdominal cancers. But now, researchers are testing HIPEC on women with advanced ovarian cancer, who otherwise would have ...